Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Samy Hadjadj and Louis Potier.
Samy Hadjadj
Connection Strength
0.746
Louis Potier
  1. Prognostic Values of Inflammatory and Redox Status Biomarkers on the Risk of Major Lower-Extremity Artery Disease in Individuals With Type 2 Diabetes. Diabetes Care. 2018 10; 41(10):2162-2169.
    View in: PubMed
    Score: 0.195
  2. Sex disparities in COVID-19 outcomes of inpatients with diabetes: insights from the CORONADO study. Eur J Endocrinol. 2021 Jul 05; 185(2):299-311.
    View in: PubMed
    Score: 0.060
  3. Predictors of hospital discharge and mortality in patients with diabetes and COVID-19: updated results from the nationwide CORONADO study. Diabetologia. 2021 04; 64(4):778-794.
    View in: PubMed
    Score: 0.058
  4. Relationship between obesity and severe COVID-19 outcomes in patients with type 2 diabetes: Results from the CORONADO study. Diabetes Obes Metab. 2021 02; 23(2):391-403.
    View in: PubMed
    Score: 0.057
  5. Routine use of statins and increased COVID-19 related mortality in inpatients with type 2 diabetes: Results from the CORONADO study. Diabetes Metab. 2021 03; 47(2):101202.
    View in: PubMed
    Score: 0.057
  6. Correction to: Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. Diabetologia. 2020 09; 63(9):1953-1957.
    View in: PubMed
    Score: 0.056
  7. Type 1 Diabetes in People Hospitalized for COVID-19: New Insights From the CORONADO Study. Diabetes Care. 2020 11; 43(11):e174-e177.
    View in: PubMed
    Score: 0.056
  8. Blood glucose levels and COVID-19. Reply to Sardu C, D'Onofrio N, Balestrieri ML et al [letter] and Lepper PM, Bals R, Jüni P et al [letter]. Diabetologia. 2020 11; 63(11):2491-2494.
    View in: PubMed
    Score: 0.056
  9. Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. Diabetologia. 2020 08; 63(8):1500-1515.
    View in: PubMed
    Score: 0.055
  10. Plasma copeptin, kidney disease, and risk for cardiovascular morbidity and mortality in two cohorts of type 2 diabetes. Cardiovasc Diabetol. 2018 08 02; 17(1):110.
    View in: PubMed
    Score: 0.049
  11. Plasma proprotein-convertase-subtilisin/kexin type 9 (PCSK9) and cardiovascular events in type 2 diabetes. Diabetes Obes Metab. 2018 04; 20(4):943-953.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.